tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Joseph Stringer, 347 are a BUY (98.3%), 6 are a HOLD (1.7%).
Analyst Joseph Stringer, currently employed at NEEDHAM, carries an average stock price target met ratio of 46.48% that have a potential upside of 40.25% achieved within 258 days.
Joseph Stringer’s has documented 667 price targets and ratings displayed on 23 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on IONS, Ionis Pharmaceuticals at 04-Sep-2026.
Analyst best performing recommendations are on RNA (AVIDITY BIOSCIENCES ).
The best stock recommendation documented was for RNA (AVIDITY BIOSCIENCES ) at 6/10/2024. The price target of $35 was fulfilled within 2 days with a profit of $7.89 (29.1%) receiving and performance score of 145.52.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 15-May-2026
$31
3 months 29 days ago
(15-May-2026)
4/22 (18.18%)
$13.11 (73.28%)
308
Buy Since 20-Jan-2026
$41
$37.23 (987.53%)
$26
4 months 27 days ago
(17-Apr-2026)
15/18 (83.33%)
$0.1 (0.24%)
100
Hold Since 02-Nov-2023
$41
$37.23 (987.53%)
$20
5 months 11 days ago
(02-Apr-2026)
14/19 (73.68%)
$0.59 (1.46%)
147
Buy Since 19-Jul-2022
$41
$37.23 (987.53%)
$48
5 months 12 days ago
(01-Apr-2026)
4/29 (13.79%)
$0.61 (1.51%)
90
Buy Since 19-Jan-2024
$41
$37.23 (987.53%)
$45
5 months 12 days ago
(01-Apr-2026)
16/28 (57.14%)
$0.61 (1.51%)
368
Which stock is Joseph Stringer most bullish on?
Which stock is Joseph Stringer most reserved on?
What Year was the first public recommendation made by Joseph Stringer?
